TPSF
EGRX

Texas Permanent School Fund’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Texas Permanent School Fund’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,338
Closed -$265K – 1545
2023
Q1 		$265K Buy
9,338
+2,422
+35% +$71.9K ﹤0.01% 1500
2022
Q4 		$202K Sell
6,916
-732
-10% -$23.3K ﹤0.01% 1492
2022
Q3 		$202K Sell
7,648
-452
-6% -$16.6K ﹤0.01% 1483
2022
Q2 		$360K Buy
8,100
+43
+0.5% +$1.98K 0.01% 1426
2022
Q1 		$399K Sell
8,057
-135
-2% -$6.48K 0.01% 1435
2021
Q4 		$417K Sell
8,192
-334
-4% -$17.3K 0.01% 1447
2021
Q3 		$476K Sell
8,526
-169
-2% -$8.31K 0.01% 1424
2021
Q2 		$372K Buy
8,695
+31
+0.4% +$1.28K ﹤0.01% 1463
2021
Q1 		$362K Sell
8,664
-648
-7% -$30.1K ﹤0.01% 1456
2020
Q4 		$434K Sell
9,312
-1,992
-18% -$93.2K 0.01% 1406
2020
Q3 		$480K Buy
11,304
+3,303
+41% +$144K 0.01% 1346
2020
Q2 		$384K Sell
8,001
-526
-6% -$26.2K 0.01% 1349
2020
Q1 		$392K Buy
8,527
+1,607
+23% +$80.6K 0.01% 1295
2019
Q4 		$416K Buy
6,920
+36
+0.5% +$2.15K 0.01% 1371
2019
Q3 		$389K Sell
6,884
-109
-2% -$6.13K 0.01% 1374
2019
Q2 		$389K Sell
6,993
-3
-0% -$156 0.01% 1376
2019
Q1 		$353K Sell
6,996
-201
-3% -$8.94K 0.01% 1402
2018
Q4 		$290K Buy
7,197
+187
+3% +$9.64K 0.01% 1406
2018
Q3 		$486K Buy
7,010
+1,638
+30% +$124K 0.01% 1345
2018
Q2 		$406K Sell
5,372
-160
-3% -$10.1K 0.01% 1398
2018
Q1 		$291K Sell
5,532
-117
-2% -$6.8K ﹤0.01% 1450
2017
Q4 		$302K Sell
5,649
-576
-9% -$32.1K ﹤0.01% 1442
2017
Q3 		$371K Buy
6,225
+529
+9% +$32K ﹤0.01% 1419
2017
Q2 		$449K Sell
5,696
-171
-3% -$14K 0.01% 1369
2017
Q1 		$487K Buy
5,867
+125
+2% +$9.29K 0.01% 1332
2016
Q4 		$456K Sell
5,742
-333
-5% -$24.2K 0.01% 1357
2016
Q3 		$425K Buy
+6,075
New +$337K 0.01% 1355

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Texas Permanent School Fund's EGRX Position: Q2 2023 in Review

Texas Permanent School Fund sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2023, closing a stake of 9,338 shares — an estimated $265K sold.

Texas Permanent School Fund first reported a position in EGRX in Q3 2016 and held it in 27 quarters. The position peaked at $487K in Q1 2017. 126 funds tracked by Wall St. Rank hold EGRX as of Q2 2023.

  • Texas Permanent School Fund reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Texas Permanent School Fund sold 9,338 Eagle Pharmaceuticals, Inc. shares in Q2 2023, an estimated $265K.
  • Texas Permanent School Fund first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2016 and held it in 27 quarters.
  • Texas Permanent School Fund's Eagle Pharmaceuticals, Inc. position peaked at $487K in Q1 2017.
  • 126 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2023.

Based on Texas Permanent School Fund's 13F filing for Q2 2023, filed 7 Aug 2023.